Latest News

  • Co-Diagnostics Presents Rapid Diagnostic Test For Coronavirus In San Francisco

    Diagnostics World News | Co-Diagnostics presented their new rapid diagnostic test for COVID-19 yesterday at the Molecular Medicine TriConference in San Francisco. The Salt Lake City, Utah, diagnostics company is among the many companies working on a rapid diagnostic test for COVID-19.

    Mar 4, 2020
  • Thermo Fisher Scientific To Acquire QIAGEN

    Diagnostics World News | QIAGEN has been acquired by Thermo Fisher Scientific in a deal valued at $11.5 billion, which includes the assumption of approximately $1.4 billion of net debt.

    Mar 3, 2020
  • New Autoinflammatory Disease Discovered

    Diagnostics World News | An international group of scientists has discovered a previously unknown autoinflammatory disease and identified its underlying biological origin.

    Mar 3, 2020
  • Thermo Fisher Scientific, NeuMoDx Molecular, Proscia, And More: News From February 2020

    Diagnostics World News | February featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Thermo Fisher Scientific, NeuMoDx Molecular, Proscia, and more.

    Feb 27, 2020
  • NIH Launches $1M Challenge For Handheld Diagnostics

    Diagnostics World News | The National Institutes of Health today launched a $1 million Technology Accelerator Challenge to spur the design and development of non-invasive, handheld, digital technologies to detect, diagnose, and guide therapies for diseases with high global and public health impact. The challenge is focused on sickle cell disease, malaria, and anemia

    Feb 26, 2020
  • Credo Diagnostics Biomedical Finalizing Rapid Point-Of-Care Molecular Test For Coronavirus Detection

    Diagnostics World News Brief | Credo Diagnostics Biomedical announced they are now finalizing a rapid point-of-care molecular test to detect the novel coronavirus in 20 minutes.

    Feb 26, 2020
  • The Value Of Imaging Data As The Missing Essential Component Of Real World Data

    Diagnostics World News| Radiology is increasingly the key to synthesizing real world evidence with sufficient quality to shape drug performance. As a diagnostic toolset, imaging is one of the oldest and most widely used and clearly interpreted methods for measurement of outcomes. It is regularly used to measure disease progression and to determine the effectiveness of medical interventions. Imaging is also a common mechanism for early identification of disease that can be automated or extended through artificial intelligence (AI).

    Feb 20, 2020